117 related articles for article (PubMed ID: 24018818)
1. BAP1 expression in cutaneous melanoma: a pilot study.
Murali R; Wilmott JS; Jakrot V; Al-Ahmadie HA; Wiesner T; McCarthy SW; Thompson JF; Scolyer RA
Pathology; 2013 Oct; 45(6):606-9. PubMed ID: 24018818
[No Abstract] [Full Text] [Related]
2. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
[TBL] [Abstract][Full Text] [Related]
3. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.
Mochel MC; Piris A; Nose V; Hoang MP
Am J Clin Pathol; 2015 Jun; 143(6):901-4. PubMed ID: 25972334
[TBL] [Abstract][Full Text] [Related]
4. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma.
Song H; Wang L; Lyu J; Wu Y; Guo W; Ren G
Oncotarget; 2017 Apr; 8(17):29080-29090. PubMed ID: 28404968
[TBL] [Abstract][Full Text] [Related]
5. Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Ann Diagn Pathol; 2020 Feb; 44():151432. PubMed ID: 31864162
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of BAP1 predicts longer survival in mesothelioma.
Farzin M; Toon CW; Clarkson A; Sioson L; Watson N; Andrici J; Gill AJ
Pathology; 2015 Jun; 47(4):302-7. PubMed ID: 25938359
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
9. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
10. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
11. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
12. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
[TBL] [Abstract][Full Text] [Related]
13. Gene of the month: BAP1.
Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
[TBL] [Abstract][Full Text] [Related]
14. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
Aung PP; Nagarajan P; Tetzlaff MT; Curry JL; Tang G; Abdullaev Z; Pack SD; Ivan D; Prieto VG; Torres-Cabala CA
Am J Dermatopathol; 2019 Mar; 41(3):167-179. PubMed ID: 30801340
[TBL] [Abstract][Full Text] [Related]
15. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
[TBL] [Abstract][Full Text] [Related]
17. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
[TBL] [Abstract][Full Text] [Related]
18. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
Ardakani NM; Palmer DL; Wood BA
Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
[No Abstract] [Full Text] [Related]
19. BAP1-inactivated spitzoid naevi.
Vilain RE; McCarthy SW; Thompson JF; Scolyer RA
Am J Surg Pathol; 2015 May; 39(5):722. PubMed ID: 25871468
[No Abstract] [Full Text] [Related]
20. A Large Skin-colored Nodule on the Plantar Foot: A Quiz. Melanoma associated with germline BAP1 mutation.
Rojek NW; Korcheva V; Leachman SA
Acta Derm Venereol; 2017 Nov; 97(10):1265-1266. PubMed ID: 28597019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
